NDC product
Fibromyalgia Relief
NDC 17312-171 · TRP Company
Key facts
| Product NDC | 17312-171 |
|---|---|
| Proprietary name | Fibromyalgia Relief |
| Nonproprietary name | BRYONIA ALBA ROOT - CAUSTICUM - LOESELIA MEXICANA WHOLE - MAGNESIUM PHOSPHATE - PULSATILLA VULGARIS - TOXICODENDRON PUBESCENS LEAF - VALERIAN |
| Substances | LOESELIA MEXICANA WHOLE, BRYONIA ALBA ROOT, CAUSTICUM, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, PULSATILLA VULGARIS, TOXICODENDRON PUBESCENS LEAF |
| Dosage form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Labeler | TRP Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA] and 2 more |
| Marketing start | May 28, 2020 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: